Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Beauty Health (SKIN) Other Non Operating Income: 2021-2025

Historic Other Non Operating Income for Beauty Health (SKIN) over the last 5 years, with Sep 2025 value amounting to $601,000.

  • Beauty Health's Other Non Operating Income fell 73.61% to $601,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $20.7 million, marking a year-over-year decrease of 41.72%. This contributed to the annual value of $33.6 million for FY2024, which is 545.44% up from last year.
  • Beauty Health's Other Non Operating Income amounted to $601,000 in Q3 2025, which was down 96.69% from $18.1 million recorded in Q2 2025.
  • In the past 5 years, Beauty Health's Other Non Operating Income ranged from a high of $18.1 million in Q2 2025 and a low of -$2.2 million during Q2 2022.
  • In the last 3 years, Beauty Health's Other Non Operating Income had a median value of $1.9 million in 2025 and averaged $5.7 million.
  • Per our database at Business Quant, Beauty Health's Other Non Operating Income crashed by 31,414.29% in 2022 and then spiked by 4,262.47% in 2024.
  • Quarterly analysis of 5 years shows Beauty Health's Other Non Operating Income stood at -$199,000 in 2021, then soared by 175.38% to $150,000 in 2022, then plummeted by 191.33% to -$137,000 in 2023, then spiked by 164.23% to $88,000 in 2024, then slumped by 73.61% to $601,000 in 2025.
  • Its Other Non Operating Income stands at $601,000 for Q3 2025, versus $18.1 million for Q2 2025 and $1.9 million for Q1 2025.